
NEWS
LIPIGON PRESS RELEASES AND NEWS
2019-10-11
“We are very happy to enter this agreement with CombiGene ,” says Stefan K Nilsson, CEO at Lipigon
2018-05-28
CARINA SCHMIDT IS ANNOUNCED NEW CHAIRPERSON OF THE BOARD
Carina Schmidt has been appointed as the Chairperson of Lipigon Pharmaceuticals, she succeeds Gisela Sitbon.
2017-12-10
LIPIGON CEO AND CO-FOUNDER STEFAN K NILSSON HAS BEEN ELECTED COMMITTEE MEMBER OF PRESTIGOUS EUROPEAN LIPOPROTEIN CLUB
The European Lipoprotein Club (ELC) is the oldest and most active European meeting in the field of lipids.
READ MORE
2017-10-11
LIPIGON PHARMACEUTICALS ENTERS INTO TARGET VALIDATION RESEARCH AGREEMENT WITH GERMAN ANTISENSE COMPANY SECARNA PHARMACEUTICALS
Lipigon Pharmaceuticals (“Lipigon”) announced today that it has entered into a Target Validation Research Agreement with Munich-based antisense therapeutics company Secarna Pharmaceuticals (“Secarna”).
READ MORE2017-09-25
LIPIGON HAS BEEN NOMINATED AS UNIVERSITY SPIN-OUT OF THE YEAR
Lipigon is nominated as this year’s spin-out company at UmeåGalan2017.
READ MORE2017-04-05
LIPIGON PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF A NEW CHAIRMAN OF THE BOARD
Effective immediately Lipigon is announcing Dr. Gisela Sitbon as new Chairman of the Board.
READ MORE
2016-12-27
LIPIGON PHARMACEUTICALS JOINS ASTRAZENECA’S BIOVENTURHUB
Starting December 2016 Lipigon joins the AZ BioVentureHub located at AstraZeneca’s site in Mölndal, Sweden.
READ MORE2016-12-20
LIPIGON WELCOMES NEW INVESTORS AND PARTNERS
Lipigon is happy to announce 3 new major partners investing in the company.
READ MORE2016-06-30
LIPIGON CEO STEFAN K. NILSSON IN INTERVIEW AS INVITED SPEAKER FOR BIOFIT 2016
Lipigon CEO Stefan K. Nilsson is an invited speaker at BioFIT 2016 in Lille, France.
READ MORE
2016-03-30
MIKAEL ELOFSSON INTERVIEWED AT ADD 2016
Lipigon board member Prof. Mikael Elofsson interviewed at ADD 2016
READ MORE2016-03-14
LIPIGON PHARMACEUTICALS AND ASTRAZENECA ENTER DRUG DISCOVERY COLLABORATION
​
Lipigon Pharmaceuticals today announced that it has entered into a research collaboration with AstraZeneca.
READ MORE2016-03-02
AVAILABLE POSITIONS
Lipigon is expanding and looking for new talents to join our team.
READ MORE
2016-02-04
LIPIGON AWARDED CONNECT´S PITCH PRIZE
Lipigon awarded Connect´s pitch prize at Biotech Umeå investment Day
READ MORE2015-12-10
LIPIGON PATENT APPLICATION PUBLISHED
Lipigon’s first patent application “New plasma lipid lowering agents”...
READ MORE2015-09-02
LIPIGON SCIENTISTS PUBLISH IN PRESTIGIOUS JOURNAL
Lipigon scientists publish SAR relationship in Eur J Med Chem.
READ MORE
2015-05-02
LIPIGON CEO TO FRONT NATIONAL SSMF CAMPAIGN
CEO Stefan K Nilsson is one of out of five promising young scientists that has been selected to front the Swedish Society for Medical Research’s fund raising campaign.
READ MORE2014-11-18
LIPIGON SIGNS DEAL WITH ASTRAZENECA
Lipigon Pharmaceuticals and AstraZeneca enter research collaboration to develop a high throughput assay for the identification of molecules that modulate lipoprotein lipase activity.
READ MORE2014-09-05
LIPIGON CEO STEFAN K NILSSON RECEIVES SSMF POSTDOCTORAL AWARD
Lipigon CEO Dr. Stefan K Nilsson has been awarded the Swedish Society for Medical Research postdoctoral support.
READ MORE
2014-06-28
LIPIGON SCIENTISTS IDENTIFIES LPL ACTIVATORS
Lipigon scientists publish results for first LPL activators
READ MORE2014-01-27
LIPIGON ATTENDS: BIOTECH UMEĂ… INVESTMENT DAY
Lipigon attends: Biotech UmeĂĄ investment Day at Grand Hotel Stockholm.
READ MORE2014-01-18
LIPIGON ATTENDS: SWISS-SWEDEN
Lipigon attends: Swiss-Sweden
READ MORE